Results 231 to 240 of about 17,983,166 (291)

Modulating Renal Fibrosis: The Emerging Role of Hepatocyte Growth Factor. [PDF]

Int J Nephrol
Ferrer A, Kim J, Byer AA, Ahmed M.
europepmc   +1 more source

Stem cell therapies for treatment of diabetes mellitus. [PDF]

Chin Med J (Engl)
Guo F, Song Y, Qin G.
europepmc   +1 more source

Hypoglycemia Due to a Hormone-Secreting Tumor. [PDF]

Dtsch Arztebl Int
Ernst P, Theis B, Franiel T.
europepmc   +1 more source

A Comprehensive Pan-Cancer Analysis Revealing IGF2 Gene as a Diagnostic and Prognostic Biomarker. [PDF]

Cureus
Abdallah W, Abbas AE, Assed AHA, Elrashid Yagoub H, Doleeb S, Abdalla A, Hamid A, Alfaki M.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Synthetic insulin-like growth factor II

Biochemical and Biophysical Research Communications, 1985
Human insulin-like growth factor II with 67 amino acid residues and three disulfide bridges has been synthesized by the solid-phase method. Homogeneity of the synthetic product is ascertained by chromatofocusing, high performance liquid chromatography and amino acid analysis.
C H, Li, D, Yamashiro, R G, Hammonds, M, Westphal   +3 more
openaire   +2 more sources

Insulin‐Like Growth Factor II Effects Mediated through Insulin‐Like Growth Factor II Receptors

Acta Paediatrica, 1990
ABSTRACT. Insulin‐like growth factor II (IGF‐II) resembles the homologous peptide insulin‐like growth factor I (IGF‐I) in that it stimulates cellular growth in vitro. This effect is generally believed to be mediated through IGF type 1 receptors; the role of the IGF type 2 receptor remains, as yet, unknown.
M, Tally, K, Hall
openaire   +2 more sources

Chemical synthesis of insulin‐like growth factor II

International Journal of Peptide and Protein Research, 1985
Human insulin‐like growth factor II (IGF‐II) with 67 amino acids and three disulfide bridges has been synthesized by the solid‐phase method. The synthetic hormone is shown to be homogeneous in high performance liquid chromatography (HPLC), high performance partition chromatography (HPPC), and chromatofocusing.
D, Yamashiro, C H, Li
openaire   +2 more sources

Immunoreactive insulin-like growth factor II in urine

Acta Endocrinologica, 1990
Abstract. Insulin-like growth factor II and insulin-like growth factor binding protein-1 were identified and quantified in the urine of 23 healthy subjects between 17 and 76 years of age. IGF-II was measured after separation by gel chromatography at low pH and compared with IGF-I levels in the same samples, whereas IGF binding protein-1 was measured in
W, Zumkeller, K, Hall
openaire   +2 more sources

Secretion of insulin-like growth factor II into milk

Biochemical and Biophysical Research Communications, 1992
125I-labeled insulin-like growth factor II (IGF-II) was infused directly into the pudic artery supplying one gland of lactating goats (n = 4). Maximum specific activity for [125I]IGF-II transferred into milk from the infused gland was reached 60 min after that in plasma and was 2.5 fold greater than in milk from the non-infused gland.
C G, Prosser, I R, Fleet
openaire   +2 more sources

Insulin-Like Growth Factor II in Hepatocellular Carcinoma

Biomarkers in Medicine, 2007
Hepatocellular carcinoma is one of the most common malignant human tumors. Hepatocarcinogenesis is a multistep process with a multifactorial etiology. Chronic hepatitis B and hepatitis C virus infection, alcohol drinking and cirrhosis of any etiology are the major risk factors for hepatocellular carcinoma.
Jeng-Eing, Jeng, Lea-Yea, Chuang, Wang-Lung, Chuang, Jan-Gowth, Chang, Jung-Fa, Tsai   +4 more
openaire   +2 more sources